possible near term events,
likely near term events based on CC info two weeks ago tomorrow.
Item #1 is the heavy hitter for me as starting trials is what ACT is all about.
1)Info posted to clinicaltrials.gov(will allow recruitment to begin)
(CC quote)
"and we expect their final approval within about two weeks."
2)EU Orphan Designation(OMP meeting April 6-7)
(CC quote)
"We have a preliminary indication that we are likely to receive orphan drug status in Europe, and are about to submit an application in Europe to their version of the FDA, the EMEA, for the same therapy"
3)Roslin Deal
(CC quote)
"This should help us significantly in licensing the cells through our Roslin Cells deal, which we are currently working to finalize"